20020220
 Business Brief -- Novartis AG: Schizophrenia Drug's Label Warns of Heart Side Effects   The Wall Street Journal,  Feb 21, 2002  Novartis AG, Basel, Switzerland, strengthened the warning label on its schizophrenia drug Clozaril, adding a possibly fatal heart condition called myocarditis to the list of possible side effects.   
